EQUITY (Details) - USD ($)			12 Months Ended
	Apr. 29, 2022	Jan. 01, 2019	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Jul. 26, 2022	Jul. 25, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares issued (in shares)			57,723,738	55,597,855
Common stock, shares outstanding (in shares)			57,723,738	55,597,855
Issuance of common stock, related expenses			$ 2,700,000	$ 4,900,000
Sale of stock, maximum consideration on transaction	$ 350,000,000
Sale of stock, agreement term	3 years
Sale of stock, number of shares issued in transaction			2,025,891	1,802,063
Proceeds from issuance of common stock, excluding employee stock purchase plans			$ 112,700,000	$ 104,600,000
Payments for commissions			1,100,000	1,100,000
Payments of stock issuance costs			$ 200,000	$ 100,000
Common stock, shares authorized (in shares)			136,000,000	136,000,000		136,000,000	68,000,000
Common stock, par value (in dollars per share)			$ 0.01	$ 0.01		$ 0.01
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares issued (in shares)			50,319	40,095	37,460
Percent of market value discount		90.00%
Maximum payroll deduction		10.00%
Maximum number of shares per employee (in shares)		2,000
Maximum value of shares per employee		$ 25,000
Issuance of common stock, related expenses			$ 300,000	$ 200,000	$ 200,000